Angiogenesis Sustains Tumor Dormancy in Patients with Breast Cancer Treated with Adjuvant Chemotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1006476401801
Reference25 articles.
1. Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G: Time distribution of the reccurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat 41: 177-185, 1996
2. Saphner T, Tormey DC, Gray R: Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14: 2738-2746, 1996
3. Karrison TG, Ferguson DJ, and Meier P: Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 91: 80-85, 1999
4. Uhr JW, Scheuermann RH, Street NE, Vitetta ES: Cancer dormancy: opportunities for new therapeutic approaches. Nature Med 3: 505-509, 1997
5. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Does Primary Tumor Resection Induce Accelerated Metastasis in Breast Cancer? A Review;Journal of Surgical Research;2023-03
2. Microvessel density assessment in canine mammary carcinomas as a predictive factor for metronomic chemotherapy;Semina: Ciências Agrárias;2019-07-04
3. Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer;Cancer Treatment Reviews;2018-11
4. Erratum to: Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference;Cancer Cell International;2017-07-12
5. Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference;Cancer Cell International;2017-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3